Liberty Health Sciences Introduces Liberty 360° Innovation Campus in Florida

Visit the Liberty Health Sciences Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Liberty Health Sciences Closes Acquisition of New Campus in Gainsville, Florida, Introduces Liberty 360° Innovation Campus

Liberty  also receives approval from Department of Health to expand existing facilities and secures new dispensary location in  South Tampa  for a total of 6 confirmed  Florida  locations to-date

TORONTO , Feb. 16, 2018 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS and OTCQX: LHSIF) (” Liberty ” or the “Company”) announced today that it has closed the acquisition of a 387-acre parcel of land in  Gainesville, Florida , previously owned by Alico Citrus Nursery, LLC. The property will become the home of the new  Liberty  360° Innovation Campus (” Liberty 360″), with state-of-the-art greenhouses and processing facilities that firmly establishes  Liberty  as one of the leading medical cannabis providers in  Florida .

We’re thrilled to establish the  Liberty  360 campus as our innovation hub for the cultivation, production and processing of high-quality, pharmaceutical-grade medical cannabis for the rapidly expanding patient demand in  Florida.

George Scorsis , Director and CEO of  Liberty

Liberty  360 will enable us to expand our production capabilities and provide a broader range of products and delivery methods to  Florida’s  patients in need. It will also serve as our center for new product innovation and development as we remain on the leading edge of the medical cannabis industry.

Liberty  360’s existing facilities, which includes over 200,000 square feet of state-of-the-art greenhouses and processing facilities will undergo a retrofit over the coming months, which will include a commercial kitchen for the production of edibles and a new 16,000-square-foot processing area for the extraction and refining of cannabis oils. It will be equipped to produce vaporizer products including preloaded disposable pens, cartridges and pods.  Liberty  will continue to offer other dosage forms such as capsules, oral solutions (tinctures) and topicals. Liberty’s ability to cultivate, process and/or produce cannabis products at this new facility will be subject to the receipt of all required approvals and/or authorizations from the Florida Department of Health, Office of Medical Marijuana Use (“DOH”).

DOH approves expansion of existing facilities

Liberty  also announced the DOH has approved the Company’s recently completed expansion of its existing facility in  Gainesville, Florida . The three new greenhouses, which add 11,000 square feet of production space, will be placed into immediate production, doubling the Company’s production capabilities to 1,600 kg per year.  Liberty  also received approval to reconfigure its facility to accommodate the production of trans-dermal and other cannabis-infused products approved by the Department of Health.

Liberty’s  Cannabis Education Centers continue to grow

Liberty’s  Cannabis Education Centers (“CEC”) are the Company’s patient-centric dispensaries designed to provide comprehensive education and resources for patients to learn about cannabis use as a safe alternative to treat symptoms related to several medical ailments. The first CEC opened in  The Villages  in  January 2018  and after just two weeks of operation it increased the Company’s total registered patients by nearly 25%.

Today the Company announced it has secured a new CEC location in  South Tampa , currently scheduled to open in the spring of 2018. This brings the total number of planned CEC locations in  Florida  to six, including in  St. Petersburg ,  Port St. Lucie ,  Fort Lauderdale  and  Fort Myers .

“Liberty  is committed to ensuring patients have convenient and timely access to its high-quality, clean and safe pharmaceutical-grade medical cannabis when they need it most,” said Scorsis. “Our Cannabis Education Centers will also provide exceptional patient care through its comprehensive educational platform which includes tools, resources and compassionate one-on-one consultations geared towards educating patients on cannabis use as a safe alternative to treat their symptoms.”

The dispensary operations and plans are being finalized and will be submitted to the Florida Department of Health, Office of Medical Marijuana Use, for approval in accordance with state law.

About Liberty Health Sciences Inc.

Liberty Health Sciences Inc. is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal.  Liberty’s  stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer.  Liberty  leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.

For more information, please visit www.libertyhealthsciences.com

Original Press Release

The most reliable, fact-based information on Liberty Health Sciences found only on its Investor Dashboard.

Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. For questions contact us.

Get Our Sunday Newsletter